Page last updated: 2024-12-05

1-nitropropane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Nitropropane: A Versatile Compound with Potential Applications

1-Nitropropane is a colorless liquid with a sweet, pungent odor. It is an organic compound with the chemical formula CH3CH2CH2NO2. It belongs to the nitroalkane family, which are characterized by the presence of a nitro group (-NO2) attached to an alkyl group.

**Importance in Research:**

1-Nitropropane holds significant interest in research due to its versatile properties and potential applications in various fields:

* **Pharmaceutical Chemistry:** 1-Nitropropane has shown promise as a potential therapeutic agent. Studies suggest its possible use in treating conditions like:
* **Diabetes:** 1-Nitropropane has been observed to improve insulin sensitivity and reduce blood glucose levels in animal models.
* **Cancer:** Research indicates its potential to inhibit tumor growth and induce apoptosis in cancer cells.
* **Neurological Disorders:** Its potential to improve cognitive function and protect against neurotoxicity has also been explored.

* **Chemical Synthesis:** As a versatile building block, 1-Nitropropane is used as a starting material in the synthesis of other organic compounds. It can be converted into various derivatives, including amines, alcohols, and carboxylic acids, which find applications in diverse industries.

* **Materials Science:** 1-Nitropropane is used as a solvent and reagent in the production of various materials, such as polymers, resins, and explosives.

* **Engine Applications:** 1-Nitropropane has been explored as a potential fuel additive due to its high energy density and ability to improve combustion efficiency.

**Safety Concerns:**

While 1-Nitropropane offers promising potential, it is important to acknowledge its inherent toxicity. Exposure can lead to various adverse health effects, including:

* **Respiratory irritation**
* **Skin and eye irritation**
* **Central nervous system effects**
* **Hepatic and renal damage**

Therefore, handling and using 1-Nitropropane require strict safety protocols and proper protective measures.

**Current Research Focus:**

Current research on 1-Nitropropane primarily focuses on:

* **Understanding its mechanisms of action in various biological systems**
* **Developing safer and more efficient synthetic routes for its production**
* **Exploring its potential as a therapeutic agent for various diseases**
* **Investigating its applications in materials science and engineering**

**Conclusion:**

1-Nitropropane is a versatile compound with significant potential in various research areas. While its toxicity demands caution, ongoing research seeks to exploit its unique properties for the benefit of medicine, materials science, and other industries. Continued investigations are crucial for understanding its full potential and ensuring its safe and responsible use.

1-nitropropane : A nitroalkane that is propane substituted at C-1 by a nitro group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7903
CHEMBL ID1449933
CHEBI ID76261
MeSH IDM0108320

Synonyms (55)

Synonym
1-nitropropane
propane, 1-nitro-
nsc6363
nsc-6363
108-03-2
wln: wn3
propane, nitro-
nitropropane
inchi=1/c3h7no2/c1-2-3-4(5)6/h2-3h2,1h
NCGC00091712-01
ccris 1329
ai3-02264
nsc 6363
hsdb 2526
einecs 203-544-9
1-nitropropane, >=98.5%
n-nitropropane
25322-01-4
N0248
A801795
NCGC00091712-02
AKOS005720804
ec 203-544-9
39w305ow99 ,
unii-39w305ow99
NCGC00256466-01
dtxsid1020980 ,
cas-108-03-2
dtxcid50980
tox21_303024
tox21_202289
NCGC00259838-01
BBL011437
STL146545
FT-0608157
1-nitropropane [inci]
nitropropane, 1-
1-nitropropane [mi]
1-nitropropane [hsdb]
3-nitropropane
CHEBI:76261 ,
1-nitro-propane
nitro-propane
CHEMBL1449933
n-c3h7no2
1-nitropan
nipar s-10
n1p ,
J-002043
1-nitropropane, analytical standard
F0001-0158
mfcd00007407
D97683
Q2567814
EN300-42942

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Differences between nitroalkanes in terms of content of nitronate tautomer at equilibrium are probably an important chemical determinant of their toxic potential."( Investigation of the chemical basis of nitroalkane toxicity: tautomerism and decomposition of propane 1- and 2-nitronate under physiological conditions.
Gescher, A; Goodwin, B; Linhart, I, 1991
)
0.28

Dosage Studied

ExcerptRelevanceReference
" 1B is not appropriate, based on the fact that rat mammary and harderian tumors are likely not relevant to humans and lung and liver tumors reported in mice were equivocal in their dose-response and statistical significance."( Hazard characterization of carcinogenicity, mutagenicity, and reproductive toxicity for short chain primary nitroalkanes.
Garnick, L; Gillie, C; Kozal, J; Maier, A; Monnot, A; Quinn, J; Spencer, P, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
primary nitroalkaneA nitroalkane in which the nitro group is attached to a terminal carbon. Major microspecies at pH 7.3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency34.93670.007215.758889.3584AID1224835
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency4.80633.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency4.24860.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency11.20140.000221.22318,912.5098AID1259243; AID1259247; AID743042
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency7.60540.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency16.18440.001022.650876.6163AID1224838; AID1224839
progesterone receptorHomo sapiens (human)Potency8.47710.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.00790.000214.376460.0339AID588532
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency5.34870.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency19.13420.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency30.97260.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency18.68570.000229.305416,493.5996AID1259244; AID743079
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency34.37620.001723.839378.1014AID743083
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency5.39280.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency5.56020.039147.5451146.8240AID1224845
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency6.73360.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency6.73360.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (38.89)18.7374
1990's5 (27.78)18.2507
2000's3 (16.67)29.6817
2010's2 (11.11)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.34 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index70.63 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]